These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20228994)

  • 61. The Effect of Pulmonary Function Testing on the Success of Smoking Cessation.
    Salepci B; Caglayan B; Fidan A; Parmaksiz ET; Kiral N; Comert SS; Dogan C; Coskun E
    Respir Care; 2016 Aug; 61(8):1073-80. PubMed ID: 26932380
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Re-Defining Lower Limit of Normal for FEV
    Hansen JE; Porszasz J; Casaburi R; Stringer WW
    Chronic Obstr Pulm Dis; 2015 Mar; 2(2):94-102. PubMed ID: 28848835
    [No Abstract]   [Full Text] [Related]  

  • 63. COPD in chronic heart failure: less common than previously thought?
    Minasian AG; van den Elshout FJ; Dekhuijzen PN; Vos PJ; Willems FF; van den Bergh PJ; Heijdra YF
    Heart Lung; 2013; 42(5):365-71. PubMed ID: 23998385
    [TBL] [Abstract][Full Text] [Related]  

  • 64. FEV3, FEV6 and their derivatives for detecting airflow obstruction in adult Chinese.
    Lam DC; Fong DY; Yu WC; Ko FW; Lau AC; Chan JW; Choo KL; Mok TY; Tam CY; Ip MS; Chan-Yeung MM
    Int J Tuberc Lung Dis; 2012 May; 16(5):681-6. PubMed ID: 22507932
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Decreased prevalence of moderate to severe COPD over 15 years in northern Sweden.
    Backman H; Eriksson B; Rönmark E; Hedman L; Stridsman C; Jansson SA; Lindberg A; Lundbäck B
    Respir Med; 2016 May; 114():103-10. PubMed ID: 27109819
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The interaction between immunoglobulin E and smoking in airflow obstruction in the elderly.
    Dow L; Coggon D; Campbell MJ; Osmond C; Holgate ST
    Am Rev Respir Dis; 1992 Aug; 146(2):402-7. PubMed ID: 1489131
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Using the Lower Limit of Normal Instead of the Conventional Cutoff Values to Define Predictors of Pulmonary Function Impairment in Subjects With Chronic Heart Failure.
    Minasian AG; van den Elshout FJ; Dekhuijzen PN; Vos PJ; Willems FF; van den Bergh PJ; Heijdra YF
    Respir Care; 2016 Feb; 61(2):173-83. PubMed ID: 26487748
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Contemporary interpretation of lung function test results].
    Quanjer P; Stam H; Mertens FW; de Jongste JC; Chavannes NH; Hoogsteden HC
    Ned Tijdschr Geneeskd; 2014; 158():A7031. PubMed ID: 24666530
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Current clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary care.
    Schermer TR; Smeele IJ; Thoonen BP; Lucas AE; Grootens JG; van Boxem TJ; Heijdra YF; van Weel C
    Eur Respir J; 2008 Oct; 32(4):945-52. PubMed ID: 18550607
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The prevalence of chronic obstructive pulmonary disease in Riyadh, Saudi Arabia: a BOLD study.
    Al Ghobain M; Alhamad EH; Alorainy HS; Al Kassimi F; Lababidi H; Al-Hajjaj MS
    Int J Tuberc Lung Dis; 2015 Oct; 19(10):1252-7. PubMed ID: 26459542
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Fixed ratio or lower limit of normal as cut-off value for FEV1/VC: an outcome study.
    Wollmer P; Engström G
    Respir Med; 2013 Sep; 107(9):1460-2. PubMed ID: 23845882
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Daily spirometric variability: normal subjects and subjects with chronic bronchitis with and without airflow obstruction.
    Rozas CJ; Goldman AL
    Arch Intern Med; 1982 Jul; 142(7):1287-91. PubMed ID: 7092446
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prevalence of undetected persistent airflow obstruction in male smokers 40-65 years old.
    Geijer RM; Sachs AP; Hoes AW; Salomé PL; Lammers JW; Verheij TJ
    Fam Pract; 2005 Oct; 22(5):485-9. PubMed ID: 15964866
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pulmonary function tests: normal values in non-smoking students and staff at the Aga Khan University, Karachi.
    Ali Baig MI; Qureshi RH
    J Coll Physicians Surg Pak; 2007 May; 17(5):265-8. PubMed ID: 17553322
    [TBL] [Abstract][Full Text] [Related]  

  • 75. COPD among non-smokers - report from the obstructive lung disease in Northern Sweden (OLIN) studies.
    Hagstad S; Ekerljung L; Lindberg A; Backman H; Rönmark E; Lundbäck B
    Respir Med; 2012 Jul; 106(7):980-8. PubMed ID: 22498109
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The accuracy of a handheld "disposable pneumotachograph device" in the spirometric diagnosis of airway obstruction in a Chinese population.
    Chen G; Jiang L; Wang L; Zhang W; Castillo C; Fang X
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2351-2360. PubMed ID: 30122915
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Increase in Airway Obstruction between 1993 and 2012 in Switzerland. An Observational Study.
    West EA; Strassmann A; Wang C; Turk A; de Hoogh K; Röösli M; Bopp M; Buist AS; Dressel H; Puhan MA
    Ann Am Thorac Soc; 2020 Apr; 17(4):457-465. PubMed ID: 31991089
    [No Abstract]   [Full Text] [Related]  

  • 78. Assessing two spirometric criteria of pre-bronchodilator and post-bronchodilator FEV1/FVC ratio in detecting air flow obstruction.
    Waheed Z; Irfan M; Haque AS; Siddiqui NH; Awan S; Syed B; Khan JA
    J Pak Med Assoc; 2011 Dec; 61(12):1172-5. PubMed ID: 22355960
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Chronic airflow obstruction in Tanzania - a cross-sectional study.
    Zoller T; Mfinanga EH; Zumba TB; Asilia PJ; Mutabazi EM; Wimmersberger D; Kurth F; Mhimbira F; Haraka F; Reither K
    BMC Pulm Med; 2018 Jan; 18(1):11. PubMed ID: 29351754
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Reference equations for spirometry from a general population sample in central Italy.
    Pistelli F; Bottai M; Carrozzi L; Baldacci S; Simoni M; Di Pede F; Viegi G
    Respir Med; 2007 Apr; 101(4):814-25. PubMed ID: 16971104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.